Webinar: Part 2 - Access to GLP-1s (medicines like Ozempic) and SGLT-2s for people living with type 2 diabetes

The MSF Access Campaign hosted a webinar on why we need newer medicines to treat people living with type 2 diabetes in low- and middle-income countries, and why people’s access to GLP-1s (eg, Ozempic) may be a major challenge.